However, the development of specific inhibitors of NF-κB will be both beneficial in dissecting the role of NF-κB in the initiation of spontaneous miscarriage and could potentially be clinically useful in the management and treatment of miscarriage. The gene discussed is NFKB1; the disease is Miscarriage.